Ambu A/S : Transactions according to share buyback programme (no. 18)
February 12, 2018 at 10:26 am EST
Share
Based on the authorization given by the general assembly to introduce a share buyback programme, the Board of Directors has initiated a share buyback programme as per 31 January 2018 as set out in European Commission Regulation No. 596/2014 of 16 April 2014, also called the 'Safe Harbour rules' as described in company announcement no. 15 dated 31 January 2018.
The share buyback programme is implemented to cover the LTI incentive programmes which were established on 22 December 2017 as described in company announcement no. 11 and 12 on 22 December 2017. During the share buyback programme which takes place from 1 February 2018 to 30 April 2018, Ambu plans to acquire own shares at a total of up to 3,850,000 shares at a total price of up to DKK 560m.
During the share buyback programme, the following transactions were conducted in the period as of 5 February up to and including 9 February 2018:
Number of shares
Average
purchase price
Value of the programme in DKK
In total, latest announcement
131,000
122.34
16,027,110
5 February 2018
65,500
112.55
7,372,241
6 February 2018
65,500
115.60
7,571,865
7 February 2018
65,500
116.52
7,632,008
8 February 2018
65,500
118.53
7,763,656
9 February 2018
65,500
115.62
7,573,254
In total during the share buyback programme
458,500
117.64
53,940,134
Following the above transactions, Ambu owns 5,495,625 shares corresponding to 2.2% of the share capital (A and B shares). During the buyback period, Ambu will each Monday in a company announcement to Nasdaq Copenhagen announce the share buyback and its value.
Download
You can download this company announcement incl. list of transactions (pdf).
Ambu A/S published this content on 12 February 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 12 February 2018 15:25:03 UTC.
Original documenthttps://www.ambu.com/about/corporate-info/investors/news/news
Public permalinkhttp://www.publicnow.com/view/FDE5A26836B74B19CB2DF255B3851062EC52DDDE
Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows:
- single-use endoscopes (56.3%);
- emergency care and resuscitation devices (22.9%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers;
- monitoring and diagnostic devices (20.8%): including electrodes used in the fields of cardiology, neurophysiology and first aid.
At the end of September 2023, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico.
Net sales are distributed geographically as follows: Denmark (1.2%), Europe (37.8%), the United States (49.5%), North America (1.3%) and other (10.2%).
AMBU A/S 
